Status:
UNKNOWN
A Predictive Score for Arterial Thrombosis Associated With Cancer
Lead Sponsor:
National and Kapodistrian University of Athens
Collaborating Sponsors:
Institut Universitaire de Cancérologie, Sorbonne University
Third Department of Medicine, Sotiria General Hospital
Conditions:
Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
Cancer is associated with an increased incidence of thrombosis and thromboembolic events are one of the leading causes of morbidity and mortality in this population. The main consideration has been gi...
Detailed Description
Cancer is associated with an increased incidence of thrombosis and thromboembolic events are one of the leading causes of morbidity and mortality in this population. The main consideration has been gi...
Eligibility Criteria
Inclusion
- Ambulatory cancer patients, with histologically confirmed solid cancer (breast, lung, gastric, colorectal, pancreatic, ovarian, prostate, or bladder cancer) or specific hematologic malignancy (Hodgkin and non-Hodgkin lymphoma or multiple myeloma) -
Exclusion
- a) age younger than 18 years, (b) life expectancy less than 3 months, (c) ongoing pregnancy, (d) recent (≤3 months) arterial thromboembolism and/or (e) major psychiatric disorder will be excluded from the study.
- \-
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05256329
Start Date
January 1 2021
End Date
December 1 2025
Last Update
February 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konstantinos Toutouzas
Athens, Greece